| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-08 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0003 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |